» Articles » PMID: 27590295

Impulsive-compulsive Behaviors in Parkin-associated Parkinson Disease

Abstract

Objective: The aim of this multicenter, case-control study was to investigate the prevalence and severity of impulsive-compulsive behaviors (ICBs) in a cohort of patients with parkin-associated Parkinson disease (PD) compared to a group of patients without the mutation.

Methods: We compared 22 patients with biallelic parkin mutations (parkin-PD) and 26 patients negative for parkin, PINK1, DJ-1, and GBA mutations (PD-NM), matched for age at onset, disease duration, levodopa, and dopamine agonist equivalent daily dose. A semistructured interview was used to diagnose each of the following ICBs: compulsive sexual behavior, compulsive buying, binge eating, punding, hobbyism, and compulsive medication use. The Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale (QUIP-RS) was adopted to rate ICB severity.

Results: Frequency of patients with at least one ICB was comparable between parkin-PD and PD-NM. Nevertheless, when analyzing the distribution of specific ICBs, a higher frequency of compulsive shopping, binge eating, and punding/hobbyism was found in the parkin-PD group. Compared to PD-NM, parkin-PD patients with ICB had younger onset age and higher frequency of smokers; in 5 patients, ICB had predated PD onset. Total and partial (compulsive buying, compulsive sexual behavior, binge eating, hobbyism/punding) QUIP-RS scores were higher in patients with parkin-PD compared to patients with PD-NM. Logistic regression analysis showed that the presence of parkin mutations was associated with smoking status and higher QUIP-RS total score.

Conclusions: Our data expand the parkin-associated phenotypic spectrum demonstrating higher frequency and severity of specific ICBs, and suggesting an association between the parkin genotype, smoking status, and ICB severity.

Citing Articles

Psychiatric Disorders and Cognitive Fluctuations in Parkinson's Disease: Changing Approaches in the First Decades of the 21st Century.

Onofrj M, De Rosa M, Russo M, Ajdinaj P, Calisi D, Thomas A Brain Sci. 2025; 14(12.

PMID: 39766432 PMC: 11727288. DOI: 10.3390/brainsci14121233.


Study on Pharmacological Treatment of Impulse Control Disorders in Parkinson's Disease.

Furdu-Lungut E, Antal C, Turcu S, Costea D, Mitran M, Mitran L J Clin Med. 2024; 13(22).

PMID: 39597851 PMC: 11594643. DOI: 10.3390/jcm13226708.


Behavioral disorders in Parkinson disease: current view.

Jellinger K J Neural Transm (Vienna). 2024; 132(2):169-201.

PMID: 39453553 DOI: 10.1007/s00702-024-02846-3.


Precision Dopaminergic Treatment in a Cohort of Parkinson's Disease Patients Carrying Autosomal Recessive Gene Variants: Clinical Cohort Data and a Mini Review.

Koros C, Simitsi A, Papagiannakis N, Bougea A, Antonelou R, Pachi I Neurol Int. 2024; 16(4):833-844.

PMID: 39195564 PMC: 11356784. DOI: 10.3390/neurolint16040062.


Genetic mutations in Parkinson's disease: screening of a selected population from North-Eastern Italy.

Bonato G, Antonini A, Pistonesi F, Campagnolo M, Guerra A, Biundo R Neurol Sci. 2024; 46(1):165-174.

PMID: 39034353 PMC: 11698772. DOI: 10.1007/s10072-024-07690-7.


References
1.
Jarbo K, Verstynen T . Converging structural and functional connectivity of orbitofrontal, dorsolateral prefrontal, and posterior parietal cortex in the human striatum. J Neurosci. 2015; 35(9):3865-78. PMC: 4461697. DOI: 10.1523/JNEUROSCI.2636-14.2015. View

2.
Evans A, Lawrence A, Potts J, MacGregor L, Katzenschlager R, Shaw K . Relationship between impulsive sensation seeking traits, smoking, alcohol and caffeine intake, and Parkinson's disease. J Neurol Neurosurg Psychiatry. 2006; 77(3):317-21. PMC: 2077692. DOI: 10.1136/jnnp.2005.065417. View

3.
Bilgic B, Bayram A, Arslan A, Hanagasi H, Dursun B, Gurvit H . Differentiating symptomatic Parkin mutations carriers from patients with idiopathic Parkinson's disease: contribution of automated segmentation neuroimaging method. Parkinsonism Relat Disord. 2012; 18(5):562-6. DOI: 10.1016/j.parkreldis.2012.02.017. View

4.
Prabhakar S, Vinish M, Das C, Anand A . Occurrence of PARK2 mutations in a never-smoker population with Parkinson's disease in North India. Neuroepidemiology. 2010; 35(2):152-9. DOI: 10.1159/000313855. View

5.
Varrone A, Pellecchia M, Amboni M, Sansone V, Salvatore E, Ghezzi D . Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkin disease. Neurology. 2004; 63(11):2097-103. DOI: 10.1212/01.wnl.0000145765.19094.94. View